首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Comparative activity of beta-lactamase inhibitors YTR 830 clavulanate and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.
【2h】

Comparative activity of beta-lactamase inhibitors YTR 830 clavulanate and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.

机译:β-内酰胺酶抑制剂YTR 830克拉维酸盐和舒巴坦与β-内酰胺组合对产生β-内酰胺酶的厌氧菌的比较活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The in vitro activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with six beta-lactams against 88 beta-lactamase-producing anaerobes were determined. When combined with the beta-lactams, the three beta-lactamase inhibitors showed no synergy against the 10 Bacteroides fragilis homology group II strains. When the beta-lactams were combined with the inhibitors, their geometric mean MICs against the remaining 78 strains were reduced from 4.2 to 150.2 micrograms/ml to 0.2 to 12.9 micrograms/ml. The activity of the beta-lactams combined with the beta-lactamase inhibitors was significantly greater than that of the beta-lactams alone against all groups except B. fragilis homology group II, with 76 to 100% of the strains susceptible to ampicillin plus inhibitor and greater than or equal to 90% susceptible to the other combinations.
机译:确定了β-内酰胺酶抑制剂YTR 830,克拉维酸盐和舒巴坦与六种β-内酰胺结合起来对88种产生β-内酰胺酶的厌氧菌的体外活性。当与β-内酰胺类药物结合使用时,三种β-内酰胺酶抑制剂对10种脆弱的拟杆菌II型同源菌株均无协同作用。当将β-内酰胺类与抑制剂组合时,它们对其余78个菌株的几何平均MIC从4.2降低至150.2微克/毫升,降至0.2至12.9毫克/毫升。 β-内酰胺类与β-内酰胺酶抑制剂联合使用对除脆弱脆弱芽孢杆菌同源组II以外的所有组的活性明显高于单独的β-内酰胺类,其中76%至100%的菌株易受氨苄青霉素加抑制剂和大于或等于90%易受其他组合影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号